Author(s): Hervé Dombret, John F. Seymour, Aleksandra Butrym, et. al. Abstract: LB-6212 Session topic: 4. Acute myeloid leukemia – Clinical Background: Older patients (pts) with AML have poor prognoses. Previous studies with a range of chemotherapy drugs or best supportive care (BSC) only have consistently shown median overall survival (OS) of 2-8...
Pro zobrazení tohoto obsahu je třeba být přihlášen.